{
  "query": "acquisition activity adverse amenorrhoea",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT03049735",
          "briefTitle": "LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Heavy Menstrual Bleeding", "Uterine Fibroid"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 388,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03103087",
          "briefTitle": "LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-09-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Heavy Menstrual Bleeding", "Uterine Fibroid"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 382,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      }
    ]
  }
}
